J&J’s Push to End Cancer Suits Meets Trial in Bankruptcy Court
Johnson & Johnson is facing a key test of its plan to use the U.S. bankruptcy system to end more than 60,000 claims that a talc-based baby powder it sold for years causes cancer, Bloomberg News reported. A group of cancer victims is asking a federal judge in New Jersey to throw out, for the second time in less than two years, the insolvency case of LTL Management, a unit that J&J created to settle lawsuits over talc-based baby powder for $8.9 billion. Tuesday marks the start of a trial in which Bankruptcy Judge Michael Kaplan will again decide whether J&J is wrongly using bankruptcy laws to force a settlement. The bankruptcy court strategy has split lawyers suing J&J into two camps: those who back the settlement and are ready to drop their lawsuits, and holdouts who want to take their claims to juries around the country instead. Last year Kaplan sided with J&J against a unified band of the top plaintiff’s law firms in the U.S., but was overruled by a federal appeals court in Philadelphia, which ordered the judge to dismiss LTL Management’s first chapter 11 bankruptcy petition. J&J responded by tweaking its legal strategy and raising its settlement offer to $8.9 billion in order to attract support from cancer victims. LTL returned to bankruptcy in April and Kaplan agreed to hold a hearing to decide if the new case fixed the legal flaws that doomed the first effort.
